首页|IL-1β表达与食管癌患者细胞免疫水平的相关性分析

IL-1β表达与食管癌患者细胞免疫水平的相关性分析

扫码查看
目的 探讨IL-1β表达与食管癌患者细胞免疫水平的相关性.方法 收集38例食管癌患者外周血标本,流式细胞仪检测血清中IL-1β的水平及CD4+T/CD8+T细胞比值;收集8例PD-1免疫治疗前后食管癌患者外周血标本,采用酶联免疫吸附法检测血清中IL-1β的水平;利用TIMER数据库分析IL-1β表达与免疫细胞浸润及关键调控基因的关系.结果 外周血中IL-1β的水平和CD4+T/CD8+T细胞比值呈负相关(P=0.047);血清中IL-1β的水平在PD-1单抗免疫治疗后显著下降(P=0.038);食管癌组织中IL-1β的表达与巨噬细胞浸润呈负相关(P=0.00241),与中性粒细胞浸润呈正相关(P=0.00324);食管癌组织中IL-1β表达与B2M(P=0.0128)和PD-L1(P=0.00174)的表达呈正相关,与TNFRSF13C的表达呈负相关(P=0.0094).结论 IL-1β的表达与食管癌患者细胞免疫水平呈负相关,其机制与抑制免疫细胞浸润有关.
The Relationship Between IL-1β Expression and Cellular Immunity in Esophageal Cancer
Objective To investigate and evaluate the relationship between IL-1β expression and cellular immunity in esophageal cancer.Methods A total of 38 patients with esophageal cancer were enrolled for the current study;Serum IL-1β level and absolute value of CD4+/CD8+T cell were detected by flow cytometer in all patients.8 patients received PD-1 immunotherapy were enrolled;Serum IL-1β level were detected by ELISA.TIMER database was utilized to analyze the effect of IL-1β on the level of immune infiltration and immune related genes in esophageal cancer.Results There was a negative correlation between the IL-1β expression and the ratio of CD4+/CD8+T cell(P=0.047);Serum IL-1β level was significantly descended after PD-1 immunotherapy(P=0.038);There was a negative correlation between the IL-1β expression and immune infiltration of macrophages(P=0.00241),while positively correlated with neutrophil infiltration(P=0.00324);The IL-1β expression was positively correlated with the expression of B2M(P=0.0128)and PD-L1(P=0.00174),but negatively correlated with the expression of TNFRSF13C(P=0.0094).Conclusion IL-1β negatively correlates with cellular immunity in esophageal cancer by suppressing immune infiltration.

IL-1βEsophageal cancerCellular immunityImmune infiltration

黄腾、鹿红、马珺、赵迪、黄维、陈乐君、于大海

展开 >

南京中医药大学附属医院江苏省中医院,江苏南京 210000

IL-1β 食管癌 细胞免疫 免疫细胞浸润

江苏省中医院科技项目江苏省中医院科技项目江苏省中医药管理局科技项目江苏省中医药管理局科技项目

Y21022Y2021ZR07YB201815YB2020009

2024

标记免疫分析与临床
中国同辐股份有限公司

标记免疫分析与临床

CSTPCD
影响因子:0.978
ISSN:1006-1703
年,卷(期):2024.31(6)